Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01424007 · ClinicalTrials.gov registry record · NA

Metabolism, Exercise and Nutrition at UCSD (MENU Study)

A NA study of Obese and Non-Diabetic, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
245
Enrollment target
1
Study location

NCT01424007: Completed NA study of Obese and Non-Diabetic, sponsored by University of California, San Diego.

NCT01424007 is a NA study of Obese and Non-Diabetic that has completed, run by University of California, San Diego. The registered enrollment target is 245 participants, above the 202-participant average among 27 other Obese trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01424007, a NA study of Obese and Non-Diabetic, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
245 participants
Enrollment target
1
Study location

Study Summary

The purpose of the MENU Study is to examine whether there is a differential weight loss response to different dietary macronutrient composition (higher carbohydrate and lower fat versus lower carbohydrate and higher monounsaturated fat \[MUFA\] or lower carbohydrate and walnut-rich higher fat diets) in a weight loss intervention in healthy obese women, depending on insulin resistance status. Blood samples will be collected to enable analysis of potential mechanisms and differential response across subgroups.

Primary Outcome

Weight loss response, depending on insulin status, to diets that differ in macronutrient composition: 1) higher carbohydrate and lower fat, 2) lower carbohydrate and higher monounsaturated fat \[MUFA\] or 3) lower carbohydrate and walnut-rich higher fat

Conditions Studied

Interventions

  • BEHAVIORAL Weight loss

Study Locations (1)

California

  • Moores UCSD Cancer Center - La Jolla

Trial Details

FieldValue
Enrollment Target 245 participants
Start Date 2011-12
Est. Completion 2016-09
Phase NA
University of California, San Diego

775 total trials

What the finished NCT01424007 record still lists

NCT01424007 is an interventional study that assigns participants to a tested intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap, above the 202-participant average among 27 other Obese trials with a reported enrollment target (21% higher).

The record links to 2 conditions, with Obese appearing as the primary indexed condition, and to 1 intervention - of which Weight loss is the first listed.

NCT01424007 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01424007 about?

NCT01424007 is a clinical study titled "Metabolism, Exercise and Nutrition at UCSD (MENU Study)". The purpose of the MENU Study is to examine whether there is a differential weight loss response to different dietary macronutrient composition (higher carbohydrate and lower fat versus lower carbohydrate and higher monounsaturated fat \[MUFA\] or lower carbohydrate and walnut-rich higher fat diets)...

What is the current status of trial NCT01424007?

This trial is currently completed. It is a NA study. The enrollment target is 245 participants. The study started on 2011-12. Estimated completion is 2016-09.

What conditions does trial NCT01424007 study?

This clinical trial studies the following conditions: Obese, Non-Diabetic.

What interventions are being tested in trial NCT01424007?

The interventions under investigation include: Weight loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT01424007?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01424007 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obese

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01424007's enrollment target sits among peer trials

245 6th of 27 higher than 22 of 27 other Obese trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obese trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03645928 · 245 participants · Phase 2

    Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

  • NCT04718168 · 245 participants · NA

    GORE® ENFORM Biomaterial Product Study

  • NCT05145127 · 245 participants · Phase 3

    Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  • NCT05446259 · 245 participants

    Degenerative Cervical Myelopathy Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01424007, the US trial registry maintained by the National Library of Medicine. NCT01424007 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.